|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:activities
|
thickens cervical mucus
inhibits ovulation
alters endometrial lining
|
|
gptkbp:appointed_by
|
oral tablet
|
|
gptkbp:approves
|
gptkb:legislation
gptkb:1970
gptkb:United_States
gptkb:Native_American_tribe
contraception
|
|
gptkbp:brand
|
gptkb:Norplant
Ovral
Ovrette
|
|
gptkbp:category
|
gptkb:X
|
|
gptkbp:class
|
progestin
|
|
gptkbp:clinical_trial
|
hormonal contraception
NC T00000123
NC T00000456
NC T00000789
|
|
gptkbp:contraindication
|
gptkb:healthcare_organization
liver disease
pregnancy
|
|
gptkbp:developed_by
|
Wyeth
|
|
gptkbp:dissolved
|
lipophilic
|
|
gptkbp:duration
|
24 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
gptkb:tablet
injection
implant
|
|
gptkbp:healthcare
|
gptkb:1970
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
norgestrel
|
|
gptkbp:ingredients
|
C21 H28 O2
|
|
gptkbp:interacts_with
|
gptkb:St._John's_Wort
antibiotics
anticonvulsants
CY P3 A4 inhibitors
|
|
gptkbp:is_atype_of
|
G03 A C03
|
|
gptkbp:is_available_on
|
generic
generic drug
|
|
gptkbp:is_often_used_in
|
gptkb:drug
|
|
gptkbp:is_used_for
|
hormone replacement therapy
contraception
|
|
gptkbp:lifespan
|
approximately 30 hours
28 hours
|
|
gptkbp:manager
|
oral
subdermal implant
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:products
|
gptkb:levonorgestrel
progesterone
etonogestrel
desogestrel
medroxyprogesterone acetate
|
|
gptkbp:side_effect
|
gptkb:historical_event
headache
nausea
hypertension
weight gain
breast tenderness
acne
mood changes
thromboembolism
|
|
gptkbp:social_structure
|
gptkb:physicist
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:traded_on
|
gptkb:Cryselle
|
|
gptkbp:type_of
|
6533-00-2
|
|
gptkbp:used_in
|
combination oral contraceptives
|
|
gptkbp:bfsParent
|
gptkb:Cryselle
|
|
gptkbp:bfsLayer
|
6
|